Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model.
about
Lasso tree for cancer staging with survival data.Reporting performance of prognostic models in cancer: a review.Critical review of prostate cancer predictive toolsValue of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patientsA systematic selection method for the development of cancer staging systemsComparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.Use of nomograms for predictions of outcome in patients with advanced bladder cancer.Risk Prediction for Prostate Cancer Recurrence Through Regularized Estimation with Simultaneous Adjustment for Nonlinear Clinical EffectsSurvival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of deliriumThe New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy.Statistical consideration for clinical biomarker research in bladder cancer.Nomograms for prostate cancer.A unified Bayesian semiparametric approach to assess discrimination ability in survival analysis.Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome.Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer.Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.A comparison of estimators to evaluate the discriminatory power of time-to-event models.An integrated tree-based classification approach to prognostic grouping with application to localized melanoma patients.Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma.Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
P2860
Q30580667-D2C9BF8F-5FFA-47A5-9DC1-24D644216D6AQ33547696-5E6F1719-2222-41E5-BE78-C3AC8DE84AD3Q34104562-01C08470-5EAA-4998-BEDF-A84C3F64CDBFQ34257142-321B0B11-38A8-4E25-A465-02ADA861ACFDQ34603789-75543E2C-521B-4A8D-9C05-AE6C7420335AQ35040215-A1907E68-6340-4E3E-908B-B7C19A82B4F3Q35076360-A7AF3FF8-6179-4C62-94E1-B178AB59DB1FQ35539227-B54E6F67-D5D8-47E9-82C0-31223EB451FEQ35642409-45599E13-6FE2-412A-A4FB-F0FA722C0A97Q36113713-6CDCCD33-A2EB-47D4-A7E9-6958A3FB6226Q36124883-81AC76E5-E5ED-4C49-9158-631241C3FE90Q36532217-86297D9D-3D27-4779-8F8E-9D2682BF0192Q36984751-D4827238-8901-4F53-9725-2D060E727DB0Q37286571-7F8B7A93-B9C3-4AD8-B936-55B721DB0B10Q37445971-1C31EA45-8BA2-4FD7-9A1D-8A57ADE6E43EQ37989102-B6155F36-71B0-42FB-9142-B2381138DDF9Q40653936-506E1627-4F38-41E0-B82E-65BC8B261761Q41814979-E3F83F51-C314-4495-AF77-229851AA46D2Q47102782-A6C696E1-1023-4D01-BB37-427D98BF502BQ47344854-60C0FCD6-CB33-4ED7-9595-8A3F6EA9552CQ51915710-07F30113-C69D-489E-BF48-6D680327F9B9Q53321440-98F25BF0-DCBC-4D10-9371-67A96688624CQ57239036-8E7273E8-0BB4-469A-8605-B95B2A3D94CB
P2860
Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparing tumour staging and g ...... ues, using thymoma as a model.
@ast
Comparing tumour staging and g ...... ues, using thymoma as a model.
@en
type
label
Comparing tumour staging and g ...... ues, using thymoma as a model.
@ast
Comparing tumour staging and g ...... ues, using thymoma as a model.
@en
prefLabel
Comparing tumour staging and g ...... ues, using thymoma as a model.
@ast
Comparing tumour staging and g ...... ues, using thymoma as a model.
@en
P2093
P2860
P1476
Comparing tumour staging and g ...... ues, using thymoma as a model.
@en
P2093
P2860
P304
P356
10.1002/1097-0258(20000815)19:15<1997::AID-SIM511>3.0.CO;2-C
P407
P577
2000-08-01T00:00:00Z